About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,766 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,766 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6801-6820 of 17,766 trials

UnknownCarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)The DERIVATE study was conceived to integrate the information resulted from clinical data, transthoracic echocardiography, and cardiac magnetic resonance (CMR) imaging to provide…NCT03352648·Chicago, Illinois and 28 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

TerminatedStudy to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney DiseaseThe purpose of this study is to determine whether BMS-813160 will reduce the amount of protein loss in the urine of subjects with type 2 diabetes and diabetic kidney diseaseNCT01752985·Birmingham, Alabama and 61 others

CompletedA Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlTo determine the effect on glycemic control and lipid parameters of the 2.5 and 5 mg. doses of BMS-298585 in drug naive subjects with Type 2 diabetes as an adjunct to diet and…NCT00246987·Anniston, Alabama and 129 others

CompletedThis Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam TreatmentThis trial, evaluating the long-term safety and tolerability of brivaracetam will provide subjects suffering from epilepsy, who may have benefited from brivaracetam as adjunctive…NCT00150800·Phoenix, Arizona and 99 others

RecruitingThe INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination ProgramThis study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children…NCT05832307·Chicago, Illinois and 1 other

RecruitingPSMA PET for Surveillance After Focal TherapyThis study is about adding PSMA PET (Prostate Specific Membrane Antigen- Positron Emission Tomography) to routine magnetic resonance imaging (MRI) scans to help detect prostate…NCT07115914·Chicago, Illinois

TerminatedLung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesThis randomized phase II/III compares rilotumumab when given together with erlotinib hydrochloride against erlotinib hydrochloride alone in treating patients with stage IV…NCT02926638·Jonesboro, Arkansas and 626 others

RecruitingTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer…NCT04267848·Anchorage, Alaska and 1150 others

RecruitingDose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord InjuryThis study aims to evaluate how different doses of acute intermittent hypoxia (AIH) affect lower-limb strength, reaction time, and responsiveness in individuals with spinal cord…NCT07739992·Chicago, Illinois

CompletedEfficacy Study of Kinto Care Coaching for Dementia Family CaregiversThe goal of this clinical trial is to evaluate Kinto's Care Coaching intervention for dementia caregivers.NCT05916664·Chicago, Illinois

CompletedSun Protection of Kidney Transplant RecipientsThis study is being done to evaluate the effectiveness of a Sun Protection Strategies internet-based program for kidney transplant recipients.NCT01646099·Chicago, Illinois

CompletedBevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as oxaliplatin, irinotecan, leucovorin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing…NCT00098787·Greenbrae, California and 109 others

CompletedProblem-solving: A Stroke Caregiver Early InterventionIntervention studies for stroke caregivers (CG's) during early caregiving are few and have met with limited success.NCT01141738·Chicago, Illinois and 3 others

CompletedThe Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearTo determine, in HIV-infected patients, whether switching to a new soft gelatin capsule formulation of saquinavir or to indinavir following prolonged use of the original hard…NCT00000848·Palo Alto, California and 15 others

CompletedTreatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)To evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral vasculature.NCT04649255·Irvine, California and 8 others

TerminatedOlorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)The purpose of this study is to determine whether olorinab is a safe and effective treatment for abdominal pain in participants with irritable bowel syndrome (IBS).NCT04043455·Birmingham, Alabama and 68 others

Active not recruitingStudy of KITE-197 in Participants With Relapsed or Refractory Large B-cell LymphomaThis study will have two Phases: Phase 1a and Phase 1b.NCT06079164·Miami, Florida and 10 others

TerminatedA Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) CancerThis is an open-label, Phase 1, dose-escalation (Segment 1) and expansion (Segment 2) study to determine the maximum tolerated dose (MTD) and/or the recommended phase two dose…NCT03360006·Orange, California and 6 others

UnknownNon-contact ECG Sensor System for COVID19The purpose of this study is two-fold. First we would like to confirm that non-contact ECG provides equivalency to current contact methods of obtaining ECG data.NCT04341506·Chicago, Illinois

SuspendedStudy of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesThis study is for people who have multiple sclerosis, acute leukemia (in remission), or long-COVID and a Body Mass Index over 27 and may struggle with cognitive issues such as…NCT06171152·Chicago, Illinois

PreviousPage 341 of 889Next

in Chicago

Heart Diseasein Chicago